Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2753 results

Sort By:

Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma

Study ID: NCT07164469
Start Date: 2026-02-28
End Date: 2033-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Fludarabine

Cyclophosphamide

CD70.CAR NK Cells

Rimiducid (AP1903)

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

Study ID: NCT07166094
Start Date: 2025-11-21
End Date: 2029-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

544

Intervention / Treatment

Rina-S

IC

Sponsor

Genmab

Source: clinicaltrials.gov

Share:
Add to list

Experience With the Use of Continuous Glucose Monitoring (CGM) Devices in People With Type 2 Diabetes Mellitus

Study ID: NCT07019753
Start Date: 2026-01
End Date: 2026-10-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

5

Intervention / Treatment
Sponsor

Research Foundation in Primary Attention Jordi Gol and Gurina

Source: clinicaltrials.gov

Share:
Add to list

The TAIL-PrEP Study

Study ID: NCT06868641
Start Date: 2026-01
End Date: 2027-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

TAIL-PrEP

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Pattern Separation in Major Depressive Disorder

Study ID: NCT07139834
Start Date: 2026-01
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

SSRI (escitalopram or sertraline)

Extended-Release Memantine

Placebo

Sponsor

Jeffrey Miller

Source: clinicaltrials.gov

Share:
Add to list

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

Study ID: NCT07142252
Start Date: 2025-11-13
End Date: 2029-05-13
Study Type

Interventional

Study Phase

Phase2

No. of Participants

66

Intervention / Treatment

Rezpegaldesleukin

Placebo

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Source: clinicaltrials.gov

Share:
Add to list

Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention

Study ID: NCT07084129
Start Date: 2025-12
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

personalized dosing adjustment of vancomycin

Sponsor

Children's Hospital of Philadelphia

Source: clinicaltrials.gov

Share:
Add to list

Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking

Study ID: NCT07214207
Start Date: 2025-12
End Date: 2030-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

250

Intervention / Treatment

Suvorexant 10 mg

Placebo

Sponsor

Ohio State University

Source: clinicaltrials.gov

Share:
Add to list

HIV, Equity, and Addiction Training (HEAT) Program

Study ID: NCT06370481
Start Date: 2026-12
End Date: 2029-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Telemedicine

Standard of care

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Ultrasound Imaging of Kidney Stones and Lithotripsy

Study ID: NCT02214836
Start Date: 2025-12-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

370

Intervention / Treatment

Verasonics Data Acquisition System (VDAS)

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list